AMVUTTRA sol inj ser pré 0.5 ml

7680690740016 CH-69074 N07XX18 01.99.0.

Reimbursement limitations:

AMVUTTRA.01

Avant de pouvoir initier le traitement, le patient doit être informé par écrit des critères …

AMVUTTRA sol inj ser pré 0.5 ml
AMVUTTRA sol inj ser pré 0.5 ml
AMVUTTRA sol inj ser pré 0.5 ml
1 / 3
google

Details

Product number
6907401
CPT
-
Packaging group
1
Unit
Fertigspritze(n)
Composition
Suspension: vutrisiranum natricum 25 mg pro dosi, natrii dihydrogenophosphas dihydricus, dinatrii phosphas dihydricus, natrii chloridum, aqua ad iniectabile, acidum phosphoricum, natrii hydroxidum, pro praeparatione, natrium < 23 mg/ml.

Articles (1)

AMVUTTRA®, Injektionslösung in einer Fertigspritze
Injektionslösung
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
16/07/2025
Patient information leaflet
Français
16/07/2025
Patient information leaflet
Italien
16/07/2025
Professional SmPC
Allemand
16/07/2025
Professional SmPC
Français
16/07/2025
Professional SmPC
Italien
16/07/2025

Detailed composition

Substance Quantity Type Category
SUS
25.0 MG Substance Wirkstoff (Principe actif)
SUS
- Substance HNIDK
SUS
- Substance HNIDK
SUS
- Substance HNIDK
SUS
- Substance HNIDK
SUS
- Substance HNIDK
SUS
- Substance HNIDK
SUS
- Substance HBESI

Reimbursement information

Public price
CHF 89440.90
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/02/2024

Authorization holder

Alnylam Switzerland GmbH

6300 Zug

Authorization information

Swissmedic authorization number
69074
Drug name
AMVUTTRA®, Injektionslösung in einer Fertigspritze
Galenic form
INJFS
ATC Code
N07XX18
Authorization status
Z
Dispensation category
B
First authorization
23/06/2023
Authorization expiration date
22/06/2028
IT number
01.99.0.
Domain
Human medicine
Field of application
Amvuttra wird zur Behandlung der hereditären Transthyretin-Amyloidose (hATTR-Amyloidose) bei erwachsenen Patienten mit Polyneuropathie der Stadien 1 oder 2 angewendet

Packaging details

Description (FR)
AMVUTTRA sol inj ser pré 0.5 ml
Description (DE)
AMVUTTRA Inj Lös Fertspr 0.5 ml
Market launch
23/06/2023
Narcotic (BTM)
No

Application methods

SUBC